This book presents a rigorous historical and scientific perspective on the evolution of biotechnology, tracing its trajectory from early experimental origins to the rise of modern and industrial biotechnology. Beginning with the foundational contributions of pioneering scientists, it illustrates how transformative discoveries reshaped microbiology and biochemistry into applied and industrially relevant technological disciplines.

The authors analyse the key forces that have driven biotechnology’s development, including scientific curiosity, exploratory ambition, technological innovation, and urgent medical and societal needs. Landmark case studies such as the development of penicillin and, more recently, RNA-based vaccines against COVID‑19 demonstrate how large-scale research initiatives have addressed critical global challenges while accelerating biotechnological progress. Beyond its scientific foundations, the book critically examines the concepts, applications, and limitations of biotechnology, addressing the tensions between academic research and commercial enterprise. It also explores the broader economic, social, and ethical implications of biotechnological innovation, highlighting conflicts, regulatory challenges, and societal responsibilities that accompany technological advancement.

Designed for researchers, graduate students, historians of science, and professionals in biotechnology and life sciences, this volume provides an authoritative and coherent framework for understanding the principles, discoveries, and innovations that continue to shape the field. It serves both as a scholarly reference and as a conceptual guide to the past, present, and future of biotechnology.

This book is a translated and updated edition of the original German edition “Eine kleine Geschichte der Biotechnologie” by the same authors, published by Springer-Verlag Germany in 2022. The translation was done with the help of artificial intelligence, and a subsequent human revision was done primarily in terms of content.

Klaus Buchholz studied chemistry at the Universities of Saarbrücken and Heidelberg, Germany. He earned his doctorate at the Technical University of Munich with a dissertation in chemical engineering. From 1970 on he conducted a research group on biochemical engineering at the DECHEMA INSTITUE, Frankfurt, Germany. He also participated in a working group on a concept for research in the field of biotechnology for the German Ministery for Education and Science (“Bildung und Wissenschaft”), which became known as “Studie Biotechnologie” of DECHEMA, published in 1974. From 1982 onward, he headed a department at the Sugar Institute of the Technical University of Braunschweig. In 1988, he was appointed Director of the Institute, and in 1991 he became a professor. His main research focus was enzyme technology, from which several textbooks on biocatalysis emerged.

John Collins studied microbiology at University College London, UK, and received his PhD in genetics from the University of Leicester. From 1971 to 1974, he conducted research at universities in San Diego, California (UCSD), USA, and in Copenhagen, Denmark. During this period, he played a significant role in pioneering work in genetic engineering. Since 1986, as a professor at the Technical University of Braunschweig and as Head of the Genetics Department (later Division Head for Cell Biology and Genetics) at the German National Center for Biotechnology Research (GBF) in Braunschweig, he has continued to advance the development of molecular genetics methods and their application in biotechnology. The German National Center for Biotechnology Research (GBF) was later renamed as the Helmholtz Center for Infection Research (HZI).